[Acyclic analogs of ribavirin. Synthesis and antiviral activity]. 1988

T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov

Activity of several ribavirin analogues, viz.1-(2-hydroxyethoxymethyl)-, 1-(3-hydroxypropoxymethyl)-, 1-(4-hydroxybutoxymethyl)- and 1-(2,3-dihydroxypropyl)-1,2,4-triazole 5- and 3-carboxamides, against human adenovirus type 2 in the Hep-2 cell culture has been studied. The ether oxygen atom imitating the ribose O4' was shown to be essential for the antiviral activity. 1-(2-Hydroxyethoxymethyl)-1,2,4-triazole 3-carboxamide, a structural analogue of ribavirin in which the hydroxyl group is apparently equivalent to the ribose 5'-OH, possesses the highest activity among the compounds studied. Lengthening of the alkyl side chain reduces essentially the antiviral activity.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000260 Adenoviruses, Human Species of the genus MASTADENOVIRUS, causing a wide range of diseases in humans. Infections are mostly asymptomatic, but can be associated with diseases of the respiratory, ocular, and gastrointestinal systems. Serotypes (named with Arabic numbers) have been grouped into species designated Human adenovirus A-G. APC Viruses,APC Virus,Adenovirus, Human,Human Adenovirus,Human Adenoviruses
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
June 1986, Bioorganicheskaia khimiia,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
September 1996, Journal of medicinal chemistry,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
January 1989, Chemistry of heterocyclic compounds,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
September 1994, Journal of medicinal chemistry,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
September 2013, Archiv der Pharmazie,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
April 1993, Journal of medicinal chemistry,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
October 2005, Current protocols in nucleic acid chemistry,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
June 2008, Chemical & pharmaceutical bulletin,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
January 2005, Nucleosides, nucleotides & nucleic acids,
T L Tsilevich, and I L Shchaveleva, and L N Nosach, and V L Zhovnovataia, and I P Smirnov
February 2009, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!